Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $41,115 | 784 | 99.8% |
| Education | $77.03 | 9 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $5,287 | 70 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $5,166 | 89 | $0 (2024) |
| ABBVIE INC. | $4,806 | 75 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $4,204 | 56 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $2,000 | 28 | $0 (2024) |
| Allergan, Inc. | $1,699 | 31 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $1,341 | 57 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,336 | 28 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,260 | 59 | $0 (2024) |
| Novo Nordisk Inc | $1,239 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,206 | 54 | AstraZeneca Pharmaceuticals LP ($837.43) |
| 2023 | $4,735 | 83 | ABBVIE INC. ($1,038) |
| 2022 | $6,693 | 108 | ABBVIE INC. ($1,754) |
| 2021 | $5,423 | 99 | AbbVie Inc. ($995.74) |
| 2020 | $3,390 | 58 | Amgen Inc. ($663.62) |
| 2019 | $4,197 | 71 | Amgen Inc. ($890.51) |
| 2018 | $6,799 | 162 | SANOFI-AVENTIS U.S. LLC ($889.45) |
| 2017 | $5,750 | 158 | AstraZeneca Pharmaceuticals LP ($637.50) |
All Payment Transactions
793 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $126.11 | General |
| Category: CNS | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Inflammation | ||||||
| 11/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $130.00 | General |
| Category: CNS | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Gastroenterology | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/01/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $140.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $121.25 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $119.78 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 10/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Inflammation | ||||||
| 09/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $114.58 | General |
| Category: DIABETES | ||||||
| 09/25/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $154.09 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 09/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Endocrinology | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $120.19 | General |
| Category: Respiratory | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: Respiratory | ||||||
| 08/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 08/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 848 | 1,984 | $269,203 | $116,760 |
| 2022 | 20 | 1,060 | 2,350 | $310,594 | $140,790 |
| 2021 | 21 | 1,061 | 2,409 | $298,717 | $130,622 |
| 2020 | 20 | 1,160 | 2,611 | $258,147 | $119,472 |
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 140 | 580 | $101,500 | $47,205 | 46.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 125 | 390 | $87,750 | $45,095 | 51.4% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 50 | 78 | $13,494 | $3,035 | 22.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 140 | 335 | $5,025 | $2,814 | 56.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 112 | 215 | $11,288 | $2,770 | 24.5% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 12 | 12 | $9,000 | $2,698 | 30.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 31 | 49 | $8,085 | $2,575 | 31.9% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 27 | 42 | $3,280 | $2,172 | 66.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 47 | 51 | $1,785 | $1,749 | 98.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 13 | 21 | $2,676 | $1,663 | 62.2% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 11 | 12 | $3,204 | $1,284 | 40.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 13 | 15 | $3,750 | $1,018 | 27.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 52 | $3,120 | $681.68 | 21.8% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 29 | 31 | $4,650 | $632.31 | 13.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 16 | 17 | $1,360 | $588.54 | 43.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 20 | 20 | $7,000 | $438.00 | 6.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 11 | 11 | $1,100 | $237.27 | 21.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 17 | 19 | $627.00 | $64.79 | 10.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 12 | 34 | $510.00 | $39.87 | 7.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 151 | 782 | $136,850 | $67,314 | 49.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 96 | 229 | $51,525 | $27,521 | 53.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 66 | 66 | $16,500 | $10,115 | 61.3% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 85 | 169 | $12,903 | $8,574 | 66.4% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2022 | 20 | 21 | $15,750 | $5,144 | 32.7% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 55 | 87 | $15,051 | $3,404 | 22.6% |
About Dr. Marina Oks, D.O
Dr. Marina Oks, D.O is a Internal Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1891790903.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marina Oks, D.O has received a total of $41,192 in payments from pharmaceutical and medical device companies, with $4,206 received in 2024. These payments were reported across 793 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($41,115).
As a Medicare-enrolled provider, Oks has provided services to 4,129 Medicare beneficiaries, totaling 9,354 services with total Medicare billing of $507,644. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Brooklyn, NY
- Active Since 06/15/2005
- Last Updated 06/28/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1891790903
Products in Payments
- FARXIGA (Drug) $3,188
- Repatha (Biological) $2,638
- JARDIANCE (Drug) $1,871
- UBRELVY (Drug) $1,864
- Aimovig (Biological) $1,288
- XIFAXAN (Drug) $1,229
- ENTRESTO (Drug) $1,124
- Vascepa (Drug) $1,097
- XARELTO (Drug) $1,089
- ELIQUIS (Drug) $1,039
- QULIPTA (Drug) $1,016
- CREON (Drug) $999.68
- VRAYLAR (Drug) $948.99
- BREZTRI (Drug) $921.32
- NURTEC ODT (Drug) $910.08
- DUPIXENT (Biological) $903.84
- Otezla (Drug) $776.76
- SOLIQUA (Drug) $686.37
- PRALUENT (Drug) $680.34
- AUSTEDO (Drug) $624.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Brooklyn
Bruce Berger, M.d, M.D
Internal Medicine — Payments: $3.0M
Dr. Jesi Ramone, Md, MD
Internal Medicine — Payments: $701,491
Dr. Ali El Atat, M.d, M.D
Internal Medicine — Payments: $426,309
Manish Parikh, Md, MD
Internal Medicine — Payments: $360,332
Dr. Samuel Uter, Md, MD
Internal Medicine — Payments: $238,375
Dr. Bharath Reddy, Md, MD
Internal Medicine — Payments: $159,733